MET and colonic neoplasm: EMI-137 (Edinburgh Molecular Imaging Ltd, Edinburgh EH16 4UX, United Kingdom), a fluorescent tracer designed to target the extracellular domain of c-Met and has absorption peak at 653 nm and emission peak at 675 nm [11] showed effectiveness in guiding resection of colorectal polyps [11], colonic tumours [12], Barret's neoplasia [13], thyroid [14] and penile cancer [15].